WO2000053789A3 - Retrovirale expressionsvektoren auf der basis von herv-ltr-sequenzen - Google Patents
Retrovirale expressionsvektoren auf der basis von herv-ltr-sequenzen Download PDFInfo
- Publication number
- WO2000053789A3 WO2000053789A3 PCT/EP2000/002064 EP0002064W WO0053789A3 WO 2000053789 A3 WO2000053789 A3 WO 2000053789A3 EP 0002064 W EP0002064 W EP 0002064W WO 0053789 A3 WO0053789 A3 WO 0053789A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cell
- expression vectors
- herv
- retroviral
- retroviral expression
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13041—Use of virus, viral particle or viral elements as a vector
- C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00918779A EP1144667A2 (de) | 1999-03-10 | 2000-03-09 | Retrovirale expressionsvektoren auf der basis von herv-ltr-sequenzen |
JP2000603410A JP2002537846A (ja) | 1999-03-10 | 2000-03-09 | Hervltr配列に基づく、レトロウイルス発現ベクター |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19910650.9 | 1999-03-10 | ||
DE19910650A DE19910650A1 (de) | 1999-03-10 | 1999-03-10 | Auf HERV-LTR-Sequenzen basierende retrovirale Expressionsvektoren |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000053789A2 WO2000053789A2 (de) | 2000-09-14 |
WO2000053789A3 true WO2000053789A3 (de) | 2001-04-05 |
Family
ID=7900460
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2000/002064 WO2000053789A2 (de) | 1999-03-10 | 2000-03-09 | Retrovirale expressionsvektoren auf der basis von herv-ltr-sequenzen |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1144667A2 (de) |
JP (1) | JP2002537846A (de) |
DE (1) | DE19910650A1 (de) |
WO (1) | WO2000053789A2 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT411262B (de) | 2001-09-27 | 2003-11-25 | Wolff Klaus Dr | Humanes endogenes retrovirus |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996028563A1 (en) * | 1995-03-09 | 1996-09-19 | Bavarian Nordic | Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy |
WO2000023606A1 (en) * | 1998-10-22 | 2000-04-27 | Medical College Of Georgia Institute, Inc. | Long terminal repeat, enhancer, and insulator sequences for use in recombinant vectors |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX9701544A (es) * | 1994-09-02 | 1998-03-31 | Gsf Forschungszentrum Umwelt | Vectores de expresion retrovirales dirigidos, no autoinactivantes. |
ATE212061T1 (de) * | 1995-03-09 | 2002-02-15 | Austrian Nordic Biotherapeutic | Rekombinante dna-vektoren für die gentherapie |
-
1999
- 1999-03-10 DE DE19910650A patent/DE19910650A1/de not_active Withdrawn
-
2000
- 2000-03-09 WO PCT/EP2000/002064 patent/WO2000053789A2/de not_active Application Discontinuation
- 2000-03-09 EP EP00918779A patent/EP1144667A2/de not_active Withdrawn
- 2000-03-09 JP JP2000603410A patent/JP2002537846A/ja active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996028563A1 (en) * | 1995-03-09 | 1996-09-19 | Bavarian Nordic | Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy |
WO2000023606A1 (en) * | 1998-10-22 | 2000-04-27 | Medical College Of Georgia Institute, Inc. | Long terminal repeat, enhancer, and insulator sequences for use in recombinant vectors |
Non-Patent Citations (3)
Title |
---|
ANDERSSEN S. ET AL.: "Comparative analyses of LTRs of the ERV-H family of primate-specific retrovirus-like elements isolated from marmoset, African green monkey, and man.", VIROLOGY, vol. 234, no. 1, 1997, pages 14 - 30, XP002132290, ISSN: 0042-6822 * |
SCHOEN U. ET AL: "Tissue specific expression and promoter activity of different HERV - LTRs.", JOURNAL OF MOLECULAR MEDICINE, vol. 75, no. 7, 1997, pages B228, XP000946480 * |
SJOTTEM E ET AL: "The promoter activity of long terminal repeats of the HERV -H family of human retrovirus-like elements is critically dependent on Sp1 family proteins interacting with a GC/GT box located immediately 3' to the TATA box.", JOURNAL OF VIROLOGY, vol. 70, no. 1, January 1996 (1996-01-01), pages 188 - 198, XP002148194 * |
Also Published As
Publication number | Publication date |
---|---|
JP2002537846A (ja) | 2002-11-12 |
WO2000053789A2 (de) | 2000-09-14 |
DE19910650A1 (de) | 2000-09-21 |
EP1144667A2 (de) | 2001-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL148021A0 (en) | Novel b7-4 molecules and uses therefor | |
IL86480A0 (en) | Recombinant dna coding for human proapolipoprotein a-i,expression vectors containing it and cells transformed by said expression vector | |
EP0305488A4 (en) | Mycobacterial recombinants and peptides | |
AU7599500A (en) | Novel gl50 molecules and uses therefor | |
EP0804609A4 (de) | NEUARTIGE AUF p53 ANSPRECHENDE GENE | |
WO2001000805A3 (en) | Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport | |
NO20024945D0 (no) | Ekspresjonsregulerende sekvenser og ekspresjonsprodukter | |
ES8801675A1 (es) | Un procedimiento para preparar relaxina-h2 humana | |
WO2001000842A3 (en) | Corynebacterium glutamicum genes encoding proteins involved in homeostasis and adaptation | |
ES8802160A1 (es) | Un procedimiento para aislar un gen de relaxina cromosomica de un ser humano o de otro primate o una especie afin | |
AU5776799A (en) | Modified hcv peptide vaccines | |
ATE288488T1 (de) | Zusammensetzungen und verfahren zur eliminierung unerwünschter zellen | |
WO2000053789A3 (de) | Retrovirale expressionsvektoren auf der basis von herv-ltr-sequenzen | |
WO2000052164A3 (en) | Potassium channel molecules and uses therefor | |
WO2002048187A3 (de) | Sekretionssignalpeptide, deren dna-sequenzen, damit herstellbare expressionsvektoren für eukaryotische zellen und deren verwendung zur biotechnologischen herstellung von protein | |
WO2001032872A3 (en) | Twik potassium channel molecules and uses therefor | |
WO2002012475A3 (en) | C1q-related factor, homologous polypeptides and therapeutic uses thereof | |
WO2003020912A3 (en) | Novel clark protein and nucleic acid molecules and uses therefor | |
AU2001253258A1 (en) | Human trp-like calcium channel protein-2 (tlcc-2) | |
WO2001081413A3 (en) | Isolated human transporter proteins, nucleic acids and uses thereof | |
AU2002234132A1 (en) | 13245, a novel human myotonic dystrophy type protein kinase and uses therefor | |
WO2001079293A3 (en) | Human cadherin molecules and uses therefor | |
WO2001044476A3 (en) | Moss genes from physcomitrella patens encoding proteins involved in the synthesis of carbohydrates | |
WO2002000709A3 (en) | Cerebellin homologous polypeptides and therapeutic uses thereof | |
WO2001066743A3 (en) | A potassium channel molecule and uses therefor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000918779 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2000 603410 Kind code of ref document: A Format of ref document f/p: F |
|
WWP | Wipo information: published in national office |
Ref document number: 2000918779 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09914665 Country of ref document: US |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000918779 Country of ref document: EP |